PET scan imaging in oncology

被引：73

作者：

Jerusalem, G

Hustinx, R

Beguin, Y

Fillet, G

机构：

[1] CHU Sart Tilman, Div Hematol & Med Oncol, Dept Med, B-4000 Liege, Belgium

[2] Univ Liege, Div Nucl Med, Dept Med, B-4000 Liege, Belgium

来源：

EUROPEAN JOURNAL OF CANCER | 2003年 / 39卷 / 11期

关键词：

fluorodeoxyglucose; positron emission tomography; staging;

D O I：

10.1016/S0959-8049(03)00374-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

With the emergence of positron emission tomography (PET) from research laboratories into routine clinical use, it is important to redefine the most appropriate use of each imaging technique. The aim of this review article is to show the potential of PET in oncology. We discuss the most promising indications and the perspectives for the future. We will also point out the shortcomings and the important questions to be answered before fully considering PET as a necessary tool in the day-to-day practice of oncology. Although many studies have documented the high accuracy of F-18-FDG PET for the detection and staging of malignant tumours and for the monitoring of therapy results in these patients, it is very important to assess the impact of the technique on patient outcome and to show cost-effectiveness from the societal viewpoint. (C) 2003 Elsevier Ltd. All rights reserved.

引用

页码：1525 / 1534

页数：10

共 68 条

[21] Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions - A meta-analysis [J].